3Karina L M, Peter P. Variable receptors controlling activation and inhibition of NK cells [J]. Current Opinion in Immunology, 2002,14 : 615-621.
4Christopher W M. David H R. Expression and function of NK cell receptors in CD8^+ T cells[J]. Current Opinion in Immunology, 2001,13 : 465-470.
5Hui L C,Zacharie B. Expression of p58. 2 or CD94/NKG2A inhibitory receptors in an NK-like cell line,YTINDY,leads to HLA class Ⅰ-mediated inhibition of cytotoxicity in the p58.2-but not the CD94/NKG2A-expressing transfectant [J]. Cellular Immunoligy, 2002,219:57-70.
6Derek M, Martin C, Lynne M,et al. Natural killer cells and their receptors [J]. Transplant Immunology,2002,10:147-164.
7Sabine M, Mariola G, Elisabeth H W,et al. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells[J].Human Immunology,2000,61 : 1059-1065.
8Matthias U,Sabine M, Valeska H,et al. Truncated HLA-G Isoforms are retained in the endoplasmic reticulum and insufficiently provide HLA-E ligands [J]. Human Immunology, 2004,65 : 200-208.
9Christopher A. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-lb by CD94/NKG2 receptors [J]. Microbes and Infection, 2000, 2:371-380.
10Middleton D, Curran M,Maxwell L. Natural killer ce-lls and their receptors[J]. Transplant Immunology,2002,10:147-164.
二级参考文献29
1Natarajan K,Dimasi N,Wang J,et al.Structure and function of natural killer cell receptors:multiple molecular solutions to self,nonself discrimination.[J].Annu Rev Immunol,2002,20:853-885.
2Holmes MA,Li PW,Petersdorf EW,et al.Structural studies of allelic diversity of the MHC class I homolog MIC-B,a stress-inducible ligand for the activating immunoreceptor NKG2D.[J].J Immunol,2002,169:1395-1400.
3Ryan JC,Naper C,Hayashi S,et al.Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.[J].Immunol Rev ,2001,181:126-137.
4Ahmad T,Marshell SE,Mulcahy-Hawes K,et al.High resolution MIC genotyping:design and application to the investigation of inflammatory bowel disease susceptibility.[J].Tissue Antigens,2002,60(2):164-179.
5Radaev S,Kattah M,Zou ZC,et al.Making sense of the diverse ligand recognition by NKG2D.[J].J Immunol,2002,169:6279-6285.
6Ho EL,Carayannopoulos LN,Poursine-Laurent J,et al.Costimulation of multiple NK cell activation receptors by NKG2D.[J].J Immunol,2002,169:3667-3675.
7Roberts AI,Lee L,Schwarz E,et al.NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment.[J].J Immunol,2001,167:5527-5530.
8Gilfillan S,Ho EL,Cella M,et al.NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.[J].Nat Immunol,2002,3(12):1150-1155.
9Zompi S,Hamerman JA,Ogasawara K,et al.NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.[J].Nat Immunol,2003,4(6):565-572.
10Trinchieri G.The choices of a natural killer.[J].Nat Immunol,2003,4(6):509-510.
